BFRI Biofrontera Inc.
$1.55▲ +6.16%
Healthcare
Other
After hours
$1.59▲ +2.58%
Sep 11, 7:57 PM ET
Volume 1.40M
Avg Volume (10D) 719.9K
Key Metrics & Fundamentals
Market Cap
$23.02M
P/E Ratio
–
Div Yield
–%
52W Range
0.56 - 1.66
% vs 50 MA
20.59%
% vs 200 MA
55.67%
RSI-14
60.1
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.60
Free Cash Flow
-$1.66M
Gross Rev
$12.00M
Gross Profit
$9.59M
EBITDA
-$302,000
COGS
$2.41M
Operating Exp
$10.12M
Operating Income
-$524,000
EBIT
-$524,000
Pretax Income
-$581,000
Net Income
-$604,000
EPS (Diluted)
-0.05
Price & Volume History
Loading chart…
Recent News
Biofrontera (BFRI) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 3:58 PM
Biofrontera Inc. Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 12:30 PM
Biofrontera Inc (BFRI) (Q2 2026) Earnings Call Highlights: Strong Ameluz Growth Drives Revenue ...
GuruFocus.com · Aug 13, 2026 11:03 PM
Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 13, 2026 2:10 PM
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth
GlobeNewswire · Aug 13, 2026 12:51 PM
BioStem Technologies, Inc. (BSEM) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 12, 2026 9:40 PM
Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Sees 51% Downside
GuruFocus.com · Aug 12, 2026 1:35 PM
Gyre Therapeutics, Inc. (GYRE) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 7, 2026 12:20 PM
CytomX Therapeutics (CTMX) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 6, 2026 11:10 PM
Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026
GlobeNewswire · Aug 5, 2026 8:15 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See BFRI's money flow as a full page
Social Sentiment
No Reddit posts found for BFRI.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.